Chief Medical Officer Toby Ferguson resigns; CEO Sandrock takes over clinical leadership

Voyager Therapeutics, Inc.

Toby Ferguson, M.D., Ph.D., resigned as CMO effective Feb 20, 2026, to pursue a new opportunity.
Resignation is not due to any disagreement with the company.
CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will assume interim oversight of clinical development programs.

item 5.02 item 8.01

Voyager Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-013897

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.